Harvard Bioscience Inc HBIO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/25/21 EST
4.33UNCH (UNCH)
Volume
383
Close
4.33quote price arrow down-0.17 (-3.78%)
Volume
297,688
52 week range
1.39 - 5.21

...

Loading . . .

KEY STATS

  • Open4.53
  • Day High4.56
  • Day Low4.30
  • Prev Close4.33
  • 52 Week High5.21
  • 52 Week High Date02/08/21
  • 52 Week Low1.39
  • 52 Week Low Date03/18/20
  • Market Cap168.78M
  • Shares Out38.98M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.64
  • 1 Year % Change67.83

RATIOS/PROFITABILITY

  • EPS (TTM)-0.17
  • P/E (TTM)-25.09
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)9.057M
  • ROE (MRQ)-8.61%
  • Revenue (MRQ)102.09M
  • Gross Margin (MRQ)56.39%
  • Net Margin (MRQ)-6.51%
  • Debt To Equity (MRQ)56.34%

EVENTS

  • Earnings Date03/10/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Harvard Bioscience Inc News

There is no recent news for this security.

Latest HBIO News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization, Websites, catalogs and through distributors. The Company's product range is organized into three commercial product families: Cell and Animal...
James Green
Chairman
Michael Rossi
Chief Financial Officer
Kenneth Olson
Vice President
Address
84 OCTOBER HILL RD
Holliston, MA
01746
United States